rich 1.0 In today’s Pharmaceutical Executive Daily, Eli Lilly announces three acquisitions totaling roughly $3 billion, the FDA approves Hepcludex as the first treatment for chronic hepatitis delta virus infection in the United States, and biotech finance leaders reflect on the lessons learned from navigating two decades of volatile markets. Pharmaceutical Executive https://audioboom.com/channels/5120049-pharmaceutical-executive Audioboom https://audioboom.com 480 95 https://audioboom.com/i/43664246/600x600/c 600 600 <iframe width="100%" height="95" src="https://embeds.audioboom.com/posts/8908128/embed?v=202301" style="background-color: transparent; display: block; padding: 0; width: 100%" frameborder="0" allowtransparency="allowtransparency" scrolling="no" title="Audioboom player" allow="autoplay" sandbox="allow-downloads allow-forms allow-popups allow-same-origin allow-scripts allow-storage-access-by-user-activation allow-top-navigation-by-user-activation"></iframe>